William Blair & Company
QGENF

William Blair & Company’s QIAGEN NV QGENF Stock Holding History

William Blair & Company’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-11,450
Closed -$227K – 2138
2013
Q2 		$227K Buy
+11,450
New +$227K ﹤0.01% 1776

Other funds holding QGENF

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

William Blair & Company's QGENF Position: Q3 2013 in Review

William Blair & Company sold out of QIAGEN NV (QGENF) in Q3 2013, closing a stake of 11,450 shares — an estimated $227K sold.

William Blair & Company first reported a position in QGENF in Q2 2013 and held it in 1 quarter. The position peaked at $227K in Q2 2013. 150 funds tracked by Wall St. Rank hold QGENF as of Q3 2013.

  • William Blair & Company reported no remaining QIAGEN NV position as of Q3 2013 after selling out during the quarter.
  • William Blair & Company sold 11,450 QIAGEN NV shares in Q3 2013, an estimated $227K.
  • William Blair & Company first reported a position in QIAGEN NV in Q2 2013 and held it in 1 quarter.
  • William Blair & Company's QIAGEN NV position peaked at $227K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2013.

Based on William Blair & Company's 13F filing for Q3 2013, filed 12 Nov 2013.